Out-patient drug policy by clinical assessment rather than financial constraints?-Reference-Cited by-同舟云学术

Out-patient drug policy by clinical assessment rather than financial constraints?

Published:2004-09 Issue:3 Volume:5 Page:274-277
ISSN:1618-7598
Container-title:The European Journal of Health Economics, formerly: HEPAC
language:en
Short-container-title:Eur J Health Econom

Author:

Pronk Marja H.,Bonsel Gouke J.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-003-0223-0.pdf

Reference6 articles.

1. Anonymous (1991) Regulation on Pharmaceutical Aid Social Health Insurance. Official Gazette 73, The Hague

2. Pronk MH, Bonsel GJ, Kuy van der A (2002) The budget control function of the Dutch Price Reference System (in Dutch). Ned Tijdschr Geneeskd 146:1729?1733

3. Anonymous (1999) Decree dated 15 February 1999 amending the Decree on Benefits under the Social Health Insurance Act in connection with amendment of the provisions regulating the right to Pharmaceutical Aid. Official Gazette 109, The Hague

4. Council of Public Health Insurances (undated) Procedure application for reimbursement of medicines. Ministry of Health, Welfare and Sport Affairs and Council of Public Health Insurances, Amstelveen

5. CVZ (xxxx) College voor zorgverzekeringen. www.cvz.nl. Cited July 1999?July 2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study;Annals of the Rheumatic Diseases;2017-12-08

2. Healthcare quality and medicine reimbursement criteria in Iran;International Journal of Pharmaceutical and Healthcare Marketing;2017-11-06

3. Cost-effectiveness inClostridium difficiletreatment decision-making;World Journal of Clinical Cases;2015

4. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?;Annals of the Rheumatic Diseases;2013-08-12

5. Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making;The European Journal of Health Economics;2013-07-18